Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 participants-Reference-Cited by-同舟云学术

Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 participants

Published:2022-12-02 Issue:48 Volume:101 Page:e32003
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Peng Ke,Li Xingyue,Wang Zhen,Li Meiling,Yang Yongjian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference50 articles.

1. The role of omega-3 fatty acids in reverse cholesterol transport: a review;Pizzini;Nutrients,2017

2. Cholesterol-lowering agents;Hadjiphilippou;Circ Res,2019

3. Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts;Hilvo;Eur J Prev Cardiol,2022

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

5. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis;Navarese;JAMA,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Home-Based Cardiac Rehabilitation with Optimized Exercise Prescriptions Using a Mobile Healthcare App in Patients with Acute Myocardial Infarction: A Randomized Controlled Trial;Life;2024-09-05

2. The value of diagnostic procedures for essential hypertension control after an early recovery period of hemorrhagic stroke (literature review);The Ukrainian Scientific Medical Youth Journal;2024-03-28

3. Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China;The Journal of Clinical Endocrinology & Metabolism;2024-03-04

4. Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis;Clínica e Investigación en Arteriosclerosis (English Edition);2024-03

5. Impact of Bempedoic acid on LDL-C reduction and cardiovascular outcomes: A comprehensive meta-analysis of randomized controlled trials;Current Problems in Cardiology;2024-02